Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T27654 |
JG26
JG-26; JG 26 |
||
JG26 is an ADAM17 inhibitor. JG26 inhibits AngII-induced EGFR transactivation and ERK activation in vascular smooth muscle cells (VSMCs). |